Steven Cohen Oyster Point Pharma, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.41 - $8.38 $369,156 - $701,481	-83,709 Reduced 4.43%	1,805,387 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $288,453 - $897,411	-80,126 Reduced 4.07%	1,889,096 $8.18 Million
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $1.13 Million - $2.33 Million	-132,219 Reduced 6.29%	1,969,222 $22.9 Million
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $16.3 Million - $30.4 Million	1,601,441 Added 320.29%	2,101,441 $38.4 Million
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $5.84 Million - $9.04 Million	500,000 New	500,000 $5.93 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.